Amy Watt is a Senior Scientist at Adaptimmune, where they have served since 2024, following a role as a Scientist starting in 2023. Previously, they worked as a Flow Cytometrist at Massachusetts General Hospital from 2015 to 2019, and held various research positions at TCR² Therapeutics Inc. from 2019 to 2020. Their early research experience includes extensive work on cardiac hypertrophy during their time at Ursinus College, where they obtained a Bachelor of Science in Biology with a minor in Biostatistics in 2014.
This person is not in any teams
This person is not in any offices